2-piperidone has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Ding, W; He, Q; Jiang, L; Liu, A; Liu, B; Liu, J; Meng, Y; Peng, G; Shi, X; Wang, C; Zhang, H; Zhou, H | 1 |
1 other study(ies) available for 2-piperidone and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Inhibition of proteasomal deubiquitinases USP14 and UCHL5 overcomes tyrosine kinase inhibitor resistance in chronic myeloid leukaemia.
Topics: Deubiquitinating Enzymes; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytes, Mononuclear; Piperidones; Proteasome Endopeptidase Complex; Protein Kinase Inhibitors; Ubiquitin Thiolesterase | 2022 |